New balloon zaps heart rhythm problem in first human test
NCT ID NCT06828939
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study tests a new balloon device that uses pulsed electric fields to treat atrial fibrillation, a common heart rhythm disorder. 75 people with short-duration AF who haven't had prior ablation will receive the procedure and be followed for one year. The goal is to see if the device can safely isolate the pulmonary veins and prevent arrhythmia recurrence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pulsed field ablation balloon device
What this could lead to
If successful, this could offer a safer, more effective way to treat atrial fibrillation with a single procedure, reducing the need for repeat treatments.
What could go wrong
This is a very early first-in-human study with only 75 people. The procedure carries risks like heart perforation, stroke, or nerve injury. Long-term benefits are not yet proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION PAROXYSMAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Na Homolce Hospital
RECRUITINGPrague, Czech Republic, Czechia